Big Pharma Split Corp.
Big Pharma Split Corp. (PRM.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRM.TO · as of Jun 8, 2026
Key Statistics
Explore Big Pharma Split Corp. Data
prm.to stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
prm.to competitorsPRM.TO
BNK.TO
ELC.V
FGX.NE
GOAT.CN
NRC.VStock Performance
Full HistoryAbout Big Pharma Split Corp.
Big Pharma Split Corp. Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invest…
what is big pharma split corp. · prm.to stock overview · big pharma split corp. company profile · who is big pharma split corp. ceo · prm.to TSX · big pharma split corp. headquarters · big pharma split corp. business segments
About Stock Overview & Key Data
Big Pharma Split Corp. (PRM.TO) is a Financial Services company in the Asset Management industry, listed on TSX since Nov 27, 2017. As of the latest trading session, PRM.TO stock price is $13.80, with a market capitalization of $17.9M. The stock has returned +22.22% over the past 12 months and -1.15% year-to-date.
In fiscal year 2025, Big Pharma Split Corp. reported revenue of $1.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Big Pharma Split Corp. (PRM.TO) stock price is $13.80. The stock is traded on TSX under the ticker symbol PRM.TO. The 52-week range is $10.71 – $15.50.